On Monday, Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA), gained 3.37% to $81.84.
Walgreens Boots Alliance, Executive Vice President and Global Chief Financial Officer George Fairweather will take part at the Morgan Stanley Global Consumer & Retail Conference. Fairweather is planned to appear at 2:20 p.m. Eastern time on Tuesday, 17 November. The conference is taking place at the Crowne Plaza Times Square in New York City.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.
Shares of Lowe’s Companies, Inc. (NYSE:LOW), inclined 2.21% to $71.64, during its last trading session.
Lowe’s declared the next generation of its Iris smart home solution, built with Microsoft Azure’s cloud technology. This latest version of Iris enhances Lowe’s smart home offering with new functionality and faster performance and comprises updated software and hardware that make Iris simpler, more intuitive and more personalized. Available online at IrisbyLowes.com and in stores nationwide, the new generation of Iris provides consumers with unmatched productivity to more easily manage, monitor and maintain their homes in an open, secure environment.
Redesigned from the ground up for a more personalized, intuitive consumer experience and support the faster on boarding of a larger product ecosystem, Iris now works with more than 75 devices. By implementing a mobile-first philosophy that focuses on simplicity, speed and customization, Lowe’s has reinvigorated the smart home. The next generation Iris mobile app and hardware more seamlessly blend the digital and physical worlds, giving users an intuitive interactive way to communicate with their home and make their lives easier.
“This year’s Iris by Lowe’s Smart Home Survey revealed that more than half (57%) of Americans prefer DIY smart home solutions, and home improvement stores are the No. 1 place they are turning to for purchase,” said Mick Koster, vice president and general manager of Iris Home Systems. “As consumers increasingly become interested in home automation, Iris will continue evolving to meet the needs of each customer’s lifestyle. This next generation of Iris delivers on the promise of the smart home recently – in a way that is right away and easily accessible and affordable for consumers across America.”
Lowe’s Companies, Inc. operates as a home improvement retailer. The company offers products for maintenance, repair, remodeling, and home decorating. It provides home improvement products under the categories of kitchens and appliances; lumber and building materials; tools and hardware; fashion fixtures; rough plumbing and electrical; lawn and garden; seasonal living; paint; home fashions; storage and cleaning; flooring; millwork; and outdoor power equipment.
Finally, Shares of Horizon Pharma PLC (NASDAQ:HZNP), ended its last trade with 5.39% gain, and closed at $18.96.
Horizon Pharma plc, declared that it has been selected as one of the Chicago Tribune’s 2015 Top 40 Small-to-Medium Sized Workplaces.
“It is a great honor to be recognized by the Chicago Tribune as one of the Top Workplaces this year,” said Timothy P. Walbert, chairman, president and chief executive officer. “We take great pride in fostering a culture of empowerment and accountability, which is a model our employees embrace. Their talent and passion are integral to our identity and truly make Horizon a great place to work.”
The Chicago Tribune Top Workplaces survey recognizes Chicago-area organizations that have created exceptional places to work and is based solely on results from an employee feedback survey. The survey was administered by Workplace Dyanmics, LLC, which is a leading research firm specializing in organizational health and workplace improvement to measure employee engagement, satisfaction and other aspects of workplace culture. The award was declared recently in a special section of the Chicago Tribune.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.